early cancer detection

SAN ANTONIO, September 1, 2026 bioAffinity Technologies, Inc. is advancing the potential use of its noninvasive CyPath® Lung test...

PALO ALTO, Calif., July 28, 2026 Guardant Health, Inc. has launched a new colorectal cancer (CRC) awareness campaign featuring...

MENLO PARK, Calif., July 16, 2026 GRAIL, Inc. has announced a strategic collaboration with Priority Health, making the Galleri®...

BRISBANE, Calif. | July 9, 2026 Freenome, an early cancer detection company advancing blood-based cancer screening technologies, has announced...

BERLIN, Germany, June 10, 2026 Vara has received CE Class IIb certification under the European Union Medical Device Regulation...

CHICAGO, Illinois, May 31, 2026 Johnson & Johnson has reported pivotal results from the Phase 1b/2 OrigAMI-4 study, demonstrating...

MENLO PARK, California, May 31, 2026 GRAIL, Inc. has unveiled compelling new results from its registrational PATHFINDER 2 study,...

PALO ALTO, California, May 28, 2026 DELFI Diagnostics has achieved a significant regulatory milestone after receiving a Clinical Laboratory...

SAN DIEGO, May 22, 2026 ClearNote Health announced that it will present new multi-cohort validation data for its Avantect®...

PALO ALTO, Calif., May 13, 2026 DELFI Diagnostics announced that it will present the first-ever clinical utility data for...